- Home
- SLS vs ORKT Comparison
SLS vs ORKT Comparison
Compare SLS & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- ORKT
- Stock Information
- Founded
- SLS 2012
- ORKT 2003
- Country
- SLS United States
- ORKT Singapore
- Employees
- SLS N/A
- ORKT N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- ORKT
- Sector
- SLS Health Care
- ORKT
- Exchange
- SLS Nasdaq
- ORKT NYSE
- Market Cap
- SLS 75.3M
- ORKT 82.9M
- IPO Year
- SLS N/A
- ORKT 2024
- Fundamental
- Price
- SLS $1.32
- ORKT $2.83
- Analyst Decision
- SLS Buy
- ORKT
- Analyst Count
- SLS 1
- ORKT 0
- Target Price
- SLS $3.00
- ORKT N/A
- AVG Volume (30 Days)
- SLS 753.9K
- ORKT 2.4M
- Earning Date
- SLS 11-13-2024
- ORKT 11-26-2024
- Dividend Yield
- SLS N/A
- ORKT N/A
- EPS Growth
- SLS N/A
- ORKT N/A
- EPS
- SLS N/A
- ORKT N/A
- Revenue
- SLS N/A
- ORKT $3,904,592.00
- Revenue This Year
- SLS N/A
- ORKT N/A
- Revenue Next Year
- SLS N/A
- ORKT N/A
- P/E Ratio
- SLS N/A
- ORKT N/A
- Revenue Growth
- SLS N/A
- ORKT N/A
- 52 Week Low
- SLS $0.50
- ORKT $1.45
- 52 Week High
- SLS $1.72
- ORKT $8.00
- Technical
- Relative Strength Index (RSI)
- SLS 60.02
- ORKT N/A
- Support Level
- SLS $1.22
- ORKT N/A
- Resistance Level
- SLS $1.39
- ORKT N/A
- Average True Range (ATR)
- SLS 0.08
- ORKT 0.00
- MACD
- SLS 0.02
- ORKT 0.00
- Stochastic Oscillator
- SLS 72.00
- ORKT 0.00
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About ORKT ORANGEKLOUD TECHNOLOGY INC
Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.